RegeneRx Biopharmaceuticals, Inc.
Biopharmaceutical company reports 2003 financial results
Published in Health Business Week, April 30th, 2004
The company had a net loss of $1,659,875 or $0.06 per share for the year ended December 31, 2003, compared with net loss of $1,404,547 or $0.05 per share for the year ended December 31, 2002.
The net loss for 2003 resulted primarily from the continued research and development expenditures related to the conduct of phase I clinical trials to study the company's product, Thymosin Beta 4 (TB4) for the treatment of chronic dermal wounds, and the administrative costs associated with managing the company's various projects.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2004-04-30)
More Articles from Health Business Week
- AMDL, Inc.
Cancer diagnostics company reports 101% increase in revenue - Agendia BV
Pharmacogenomics firm closes series A financing round - Alliance for Lupus Research
Lupus group announces $6.7M in research grants - Amgen, Inc.
Tularik to be acquired for $1.3B - Business & Finance
Magellan reports 2003 revenue of $1.5B; headquarters moved to Connecticut - Business & Finance
Miracor Diagnostics reports increased net revenue in 2003 - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
